Cutler Group LP Compass Pathways PLC Call Options Transaction History

Cutler Group LP

10 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2023 Nov 07, 2023	SELL	N/A	-400 Reduced 80.0%	100 $0
Q2 2023 Jul 18, 2023	BUY	$7.79 - $10.69 $3,116 - $4,276	400 Added 400.0%	500 $0
Q1 2023 May 01, 2023	SELL	$7.32 - $10.85 $21,960 - $32,550	-3,000 Reduced 96.77%	100 $0
Q2 2022 Aug 04, 2022	SELL	$6.76 - $14.18 $3,380 - $7,090	-500 Reduced 13.89%	3,100 $1,000
Q1 2022 Apr 14, 2022	SELL	$11.13 - $23.04 $313,866 - $649,728	-28,200 Reduced 88.68%	3,600 $3,000

Q4 2021 Jan 18, 2022	BUY	$21.81 - $48.96 $202,833 - $455,328	9,300 Added 41.33%	31,800 $25,000
Q3 2021 Oct 26, 2021	SELL	$29.03 - $38.62 $14,515 - $19,310	-500 Reduced 2.17%	22,500 $130,000
Q2 2021 Jul 19, 2021	BUY	$32.29 - $39.68 $410,083 - $503,936	12,700 Added 123.3%	23,000 $52,000
Q1 2021 Apr 26, 2021	SELL	$34.75 - $57.5 $83,400 - $138,000	-2,400 Reduced 18.9%	10,300 $10,000
Q4 2020 Jan 21, 2021	BUY	$32.0 - $59.2 $406,400 - $751,840	12,700 New	12,700 $71,000

133

27.2M

108K

172K

Ticker CMPS
Exchange NASDAQ
Sector Healthcare
Industry Medical Care Facilities
Shares Outstandng 42,522,400
Market Cap $363M
Description
COMPASS Pathways plc operates as a mental health care company primarily in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy that has completed Phase IIb clinical trials for the treatment of treatment-resistant depression; and is in Phase II clinical trials for the treatment of post-traumatic stress disorder. Th...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.